【结 构 式】 |
【分子编号】58942 【品名】 【CA登记号】 |
【 分 子 式 】C10H10LiNO2 【 分 子 量 】183.13594 【元素组成】C 65.59% H 5.5% Li 3.79% N 7.65% O 17.47% |
合成路线1
该中间体在本合成路线中的序号:(XV)In a different procedure, 3,4-dichlorophenylacetic acid (XIV) was condensed with the lithiated chiral oxazolidinone (XV), via activation as the mixed anhydride with pivaloyl chloride, to afford the N-acyl oxazolidinone (XVI). Diastereoselective alkylation of the sodium enolate of (XVI) with allyl iodide (XVII) afforded the (S)-pentenyl oxazolidinone (XVIII), which was further hydrolyzed to the chiral acid (XIX) by means of lithium peroxide. Alternatively, acid (XIX) was obtained by alkylation of the lithium dianion of 3,4-dichlorophenylacetic acid (XIV) with allyl bromide (XX), followed by resolution of the resultant racemic acid (XXI) with (S)-1-phenylethylamine. Acid (XIX) was converted to the amide (XXII) via the corresponding acid chloride. Reduction of amide (XXII) with DIBAL gave the secondary amine (XXIII), which was subsequently acylated with benzoyl chloride, yielding benzamide (XXIV). Dihydroxylation of the olefin double bond with N-methylmorpholine-N-oxide in the presence of OsO4, followed by oxidative cleavage of the resultant diol (XXV) with sodium periodate furnished aldehyde (XXVI). Finally, reductive amination of aldehyde (XXVI) with piperidine (III) in the presence of NaBH3CN provided the title compound
【1】 Hale, J.J.; Finke, P.E.; MacCross, M.; A facile synthesis of the novel neurokinin A antagonist SR 48968. Bioorg Med Chem Lett 1993, 3, 2, 319. |
【2】 Finke, P.E.; Mills, S.G.; Hale, J.J.; MacCoss, M. (Merck & Co., Inc.); Process of making chiral 2-aryl-1,4-butanediamine derivs.. WO 9407839 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(III) | 59283 | N-(4-phenyl-4-piperidinyl)acetamide | C13H18N2O | 详情 | 详情 | |
(XIV) | 30414 | 2-(3,4-dichlorophenyl)acetic acid;2-(3,4-Dichlorophenyl)acetic acid | 5807-30-7 | C8H6Cl2O2 | 详情 | 详情 |
(XV) | 58942 | C10H10LiNO2 | 详情 | 详情 | ||
(XVI) | 62381 | (4S)-4-benzyl-3-[2-(3,4-dichlorophenyl)acetyl]-1,3-oxazolidin-2-one | C18H15Cl2NO3 | 详情 | 详情 | |
(XVII) | 32112 | 3-iodo-1-propene;3-iodo-propen;allyl iodide | 556-56-9 | C3H5I | 详情 | 详情 |
(XVIII) | 62382 | (4S)-4-benzyl-3-[(2S)-2-(3,4-dichlorophenyl)-4-pentenoyl]-1,3-oxazolidin-2-one | C21H19Cl2NO3 | 详情 | 详情 | |
(XIX) | 62383 | (2S)-2-(3,4-dichlorophenyl)-4-pentenoic acid | C11H10Cl2O2 | 详情 | 详情 | |
(XX) | 11463 | 3-Bromo-1-propene; 3-Bromopropene;allyl bromide | 106-95-6 | C3H5Br | 详情 | 详情 |
(XXI) | 50421 | 2-(3,4-dichlorophenyl)-4-pentenoic acid | C11H10Cl2O2 | 详情 | 详情 | |
(XXII) | 62384 | (2S)-2-(3,4-dichlorophenyl)-N-methyl-4-pentenamide | C12H13Cl2NO | 详情 | 详情 | |
(XXIII) | 62385 | (2S)-2-(3,4-dichlorophenyl)-N-methyl-4-penten-1-amine; N-[(2S)-2-(3,4-dichlorophenyl)-4-pentenyl]-N-methylamine | C12H15Cl2N | 详情 | 详情 | |
(XXIV) | 62386 | N-[(2S)-2-(3,4-dichlorophenyl)-4-pentenyl]-N-methylbenzamide | C19H19Cl2NO | 详情 | 详情 | |
(XXV) | 62387 | N-[(2S)-2-(3,4-dichlorophenyl)-4,5-dihydroxypentyl]-N-methylbenzamide | C19H21Cl2NO3 | 详情 | 详情 | |
(XXVI) | 26943 | N-[(2S)-2-(3,4-dichlorophenyl)-4-oxobutyl]-N-methylbenzamide | C18H17Cl2NO2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(XII)Alternatively, 8-bromo-1-octene (IX) is converted into the corresponding Grignard reagent (X) which is further carboxylated by solid carbon dioxide in cold THF to produce acid (XI). Coupling of acid (XI) with the lithium derivative of (S)-4-benzyl-2-oxazolidinone (XII), via activation with pivalic anhydride, leads to the chiral N-acyl oxazolidinone (XIII). Stereoselective alpha-azidation of the potassium enolate of (XIII) with trizylazide forms the (S)-azide (XIV). Subsequent reduction of azide (XIV) employing SnCl2 leads to amine (XV), which is further protected as the N-Boc derivative (XVI) with Boc2O in the presence of NaHCO3. Then, hydrolysis of the chiral auxiliary of (XVI) by means of lithium hydroperoxide gives rise to the desired N-Boc aminoacid (VIII).
【1】 Halmos, T.; Llinas-Brunet, M.; Faucher, A.-M.; Ghiro, E.; Goudreau, N.; Tsantrizos, Y.S.; Cameron, D.R. (Boehringer Ingelheim (Canada) Ltd.); Macrocyclic peptides active against the hepatitis C virus. EP 1169339; JP 2002542160; WO 0059929 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VIII) | 58938 | (2S)-2-[(tert-butoxycarbonyl)amino]-8-nonenoic acid | C14H25NO4 | 详情 | 详情 | |
(IX) | 58939 | 8-Bromo-1-octene | C8H15Br | 详情 | 详情 | |
(X) | 58940 | bromo(7-octenyl)magnesium | C8H15BrMg | 详情 | 详情 | |
(XI) | 58941 | 8-nonenoic acid | C9H16O2 | 详情 | 详情 | |
(XII) | 58942 | C10H10LiNO2 | 详情 | 详情 | ||
(XIII) | 58943 | (4S)-4-benzyl-3-(8-nonenoyl)-1,3-oxazolidin-2-one | C19H25NO3 | 详情 | 详情 | |
(XIV) | 58944 | (4S)-3-[(2S)-2-azido-8-nonenoyl]-4-benzyl-1,3-oxazolidin-2-one | C19H24N4O3 | 详情 | 详情 | |
(XV) | 58945 | (4S)-3-[(2S)-2-amino-8-nonenoyl]-4-benzyl-1,3-oxazolidin-2-one | C19H26N2O3 | 详情 | 详情 | |
(XVI) | 58946 | tert-butyl (1S)-1-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]carbonyl}-7-octenylcarbamate | C24H34N2O5 | 详情 | 详情 |